Does WARFARIN Cause Mobility decreased? 89 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Mobility decreased have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.2% of all adverse event reports for WARFARIN.
89
Reports of Mobility decreased with WARFARIN
0.2%
of all WARFARIN reports
12
Deaths
60
Hospitalizations
How Dangerous Is Mobility decreased From WARFARIN?
Of the 89 reports, 12 (13.5%) resulted in death, 60 (67.4%) required hospitalization, and 9 (10.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 89 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)